intranasal dexmedetomidine plus buccal midazolam for MRI sedation in children

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-17013328

Enrollment

Unknown

Registered

2017-11-10

Start date

2017-11-18

Completion date

Unknown

Last updated

2017-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The disease which need MRI scan

Interventions

1:intranasal dexmedetomidine at 3g.kg-1 plus buccal midazolam at 0.2mg.kg-1

Eligibility

Sex/Gender

All

Age

No minimum to 10 Years

Inclusion criteria

Inclusion criteria: Children with ASA physical status 1 to 3, aged 0~10 years who scheduled for MRI test under sedation will be recruited.

Exclusion criteria

Exclusion criteria: Exclusion criteria includes known allergy to study drugs, cardia arrhythmia.

Design outcomes

Primary

Measure	Time frame
sedation success rate;	—

Secondary

Measure	Time frame
onset time;wakeup time;adverse reaction;	—

Countries

China

Contacts

Public ContactBilian Li

Guangzhou Women and Chiidren's Medical Centre

13570226780@126.com+86 13570226780

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026